Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Myriad Genetics, Inc. shares valued at $572,835 were sold by Riggsbee Richard Bryan on Dec 01 ’23. At $19.09 per share, Riggsbee Richard Bryan sold 30,000 shares. The insider’s holdings dropped to 291,812 shares worth approximately $6.99 million following the completion of this transaction.
Also, Riggsbee Richard Bryan sold 30,000 shares, netting a total of over 470,622 in proceeds. Following the sale of shares at $15.69 each, the insider now holds 321,812 shares.
Before that, SPIEGELMAN DANIEL K had sold 8,638 shares from its account. In a trade valued at $198,760, the Director traded Myriad Genetics, Inc. shares for $23.01 each. Upon closing the transaction, the insider’s holdings decreased to 8,638 shares, worth approximately $0.97 million.
As published in a research note from Leerink Partners on May 08, 2024, Myriad Genetics, Inc. [MYGN] has been rated up from a Market perform to an Outperform and the price target has been revised to $35 from $25. As of December 19, 2023, Wells Fargo has initiated its “an Equal weight” rating for MYGN. Earlier on December 14, 2023, Guggenheim initiated its rating. Their recommendation was “a Buy” for MYGN stock.
Analyzing MYGN Stock Performance
During the last five days, there has been a surge of approximately 23.01%. Over the course of the year, Myriad Genetics, Inc. shares have jumped approximately 25.13%. Shares of the company reached a 52-week high of $24.20 on 05/08/24 and a 52-week low of $17.18 on 01/08/24. A 50-day SMA is recorded $20.64, while a 200-day SMA reached $19.06. Nevertheless, trading volume fell to 2.59 million shares from 0.64 million shares the previous day.
Support And Resistance Levels for Myriad Genetics, Inc. (MYGN)
According to the 24-hour chart, there is a support level at 22.65, which, if violated, would cause prices to drop to 21.36. In the upper region, resistance lies at 24.72. The next price resistance is at 25.50. RSI (Relative Strength Index) is 74.57 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.83, which suggests the price will increase in the coming days. Percent R is at 3.97%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
